Target intelligence / Profile preview

CTTNBP2 N-terminal-like protein (CTTNBP2NL)

Target
CTTNBP2NL
Molecular classification
Other (scaffold/adaptor protein, cytoskeletal-associated)
01

Overview

CTTNBP2 N-terminal-like protein (CTTNBP2NL) is a paralog of cortactin-binding protein 2 (CTTNBP2) and is highly conserved across mammalian species[1][4]. It shares moderate sequence similarity, especially at the N-terminus and coiled-coil domain, with CTTNBP2, but its expression profile and functional roles are distinct. Unlike CTTNBP2, which is predominately expressed in the brain and regulates dendritic spine formation and synaptic protein distribution, CTTNBP2NL is expressed at low levels in the brain and instead localizes to actin stress fibers, not to neuronal dendritic spines[1][4]. CTTNBP2NL interacts with cortactin and striatin family proteins, suggesting a role in cytoskeletal arrangement and potentially in PP2A regulatory complexes[1]. However, current evidence does not support a direct role for CTTNBP2NL in dendritic spine development, synaptic function, or as a disease biomarker or therapeutic target[1][4]. No drugs are known to interact with this protein, and there are no established safety concerns or mechanisms of drug action.

Other names
KIAA1433DKFZp547A023CTTNBP2 N-terminal likeCTTNBP2NL
02

Biological functions

Associates with stress fibersInteracts with cortactinInteracts with striatin family proteins (regulators of PP2A)Putatively involved in cytoskeletal organization
03

Disease associations

Other (no direct disease association known; functions differentiated from those of its paralog CTTNBP2, which is linked to neurological disease)

Beyond the preview

Go deeper on CTTNBP2 N-terminal-like protein (CTTNBP2NL).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CTTNBP2 N-terminal-like protein (CTTNBP2NL).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call